Grady Mike, Katz Laurence Barry, Anderson Pamela, Levy Brian Leonard
LifeScan Scotland Ltd, Inverness, United Kingdom.
LifeScan Inc, West Chester, PA, United States.
JMIR Diabetes. 2018 Jan 9;3(1):e1. doi: 10.2196/diabetes.9143.
We previously demonstrated in patients with diabetes that displaying blood glucose results in association with color improved their ability to interpret glucose results.
The objective of this study was to investigate the perceptions of health care professionals (HCPs) in specific countries about the value of color on a new glucose meter and to determine if HCP perspectives among countries differ on the value of this approach in clinical practice.
A total of 180 HCPs, including 105 endocrinologists, 34 primary care physicians, 25 diabetes educators, and 16 pharmacists, were recruited from India (n=50), Russia (n=50), China (n=50), and the United States (n=30). These HCPs experienced the OneTouch Select Plus Simple glucose meter online from their own office computer using interactive demonstrations (webpages, meter simulator, and video clips). After providing demographic and current clinical practice insights, HCPs responded to questions about the utility of the color-enhanced glucose meter.
Mean age and years in their current professional role for the 180 HCPs was 41.3 (SD 8.1) and 13.3 (SD 6.8) years for endocrinologists, 41.3 (SD 8.3) and 14.1 (SD 6.8) years for primary care physicians, 37.5 (SD 8.7) and 12.7 (SD 6.8) years for diabetes educators, and 35.9 (SD 5.3) and 9.5 (SD 5.2) years for pharmacists. In all, 88% (44/50) of Russian and 83% (25/30) of American HCPs said their patients find it easy to recognize low, in-range, or high blood glucose results compared to 56% (28/50) of HCPs in China and 42% (21/50) in India. Regardless of country, HCPs had less confidence that their patients act on blood glucose results with 52% (26/50) in Russia, 63% (19/30) in the United States, 60% (30/50) in China, and 40% (20/50) in India responding positively. During the interactive online meter experience, HCPs from all countries responded positively to questions about a meter with color features. After reflecting on the value of this meter, most HCPs strongly agreed or agreed their patients would be more inclined to act on results using a meter with color features (Russia: 92%, 46/50; United States: 70%, 21/30; China: 98%, 49/50; India: 94%, 47/50). They also said that color was particularly useful for patients with lower numeracy or education who may struggle with interpreting results (Russia: 98%, 49/50; United States: 77%, 23/30; China: 100%, 50/50; India: 82%, 41/50).
This multicountry online study provides evidence that HCPs had high overall satisfaction with the OneTouch Select Plus glucose meter, which uses color-coded information to assist patients with interpreting blood glucose results. This may be especially helpful in patient populations with low numeracy or literacy and limited access to health care and direct interaction with HCPs.
我们之前在糖尿病患者中证明,将血糖结果与颜色关联显示可提高他们解读血糖结果的能力。
本研究的目的是调查特定国家的医疗保健专业人员(HCP)对新型血糖仪上颜色的价值的看法,并确定各国HCP对这种方法在临床实践中的价值的观点是否存在差异。
从印度(n = 50)、俄罗斯(n = 50)、中国(n = 50)和美国(n = 30)招募了总共180名HCP,包括105名内分泌学家、34名初级保健医生、25名糖尿病教育者和16名药剂师。这些HCP通过交互式演示(网页、血糖仪模拟器和视频片段)从他们自己办公室的电脑上在线体验了OneTouch Select Plus Simple血糖仪。在提供人口统计学和当前临床实践见解后,HCP回答了关于颜色增强型血糖仪效用的问题。
180名HCP中,内分泌学家的平均年龄和当前专业工作年限分别为41.3(标准差8.1)岁和13.3(标准差6.8)年,初级保健医生为41.3(标准差8.3)岁和14.1(标准差6.8)年,糖尿病教育者为37.5(标准差8.7)岁和12.7(标准差6.8)年,药剂师为35.9(标准差5.3)岁和9.5(标准差5.2)年。总体而言,88%(44/50)的俄罗斯HCP和83%(25/30)的美国HCP表示,与中国56%(28/50)的HCP和印度42%(21/50)的HCP相比,他们的患者发现识别低血糖、正常范围血糖或高血糖结果很容易。无论哪个国家,HCP对其患者根据血糖结果采取行动的信心较低,俄罗斯为52%(26/50),美国为63%(19/30),中国为60%(30/50),印度为40%(20/50)给出肯定回答。在交互式在线血糖仪体验中,来自所有国家的HCP对关于具有颜色特征的血糖仪的问题都给予了积极回应。在思考这种血糖仪的价值后,大多数HCP强烈同意或同意他们的患者会更倾向于根据具有颜色特征的血糖仪的结果采取行动(俄罗斯:92%,46/50;美国:70%,21/30;中国:98%,49/50;印度:94%,47/50)。他们还表示,颜色对算术能力或教育程度较低、可能难以解读结果的患者特别有用(俄罗斯:98%,49/50;美国:77%,23/30;中国:100%,50/50;印度:8